Does cellular iron dysregulation play a causative role in Parkinson's disease?

被引:110
|
作者
Kaur, D [1 ]
Andersen, J [1 ]
机构
[1] Buck Inst Aging Res, Novato, CA 94945 USA
关键词
Parkinson's disease; oxidative stress; iron; iron regulatory proteins; mitochondrial dysfunction; alpha-synuclein;
D O I
10.1016/j.arr.2004.01.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Selective dopaminergic cell loss in Parkinson's disease is correlated with increased levels of cellular iron. It is still hotly debated as to whether the increase in iron is an upstream event which acts to promote neurodegeneration via formation of oxidative stress or whether iron accumulates as a by-product of the neuronal cell loss. Here we review evidence for loss of iron homeostasis as a causative factor in disease-associated neurodegeneration and the primary players which may be involved. A series of recent studies suggest that iron regulatory proteins (IRPs) coordinate both cellular iron levels and energy metabolism, both of which are disrupted in Parkinson's disease (PD) and may in turn contribute to increased levels of oxidative stress associated with the disease. Iron has also been recently been implicated in promotion of alpha-synuclein aggregation either directly or via increasing levels of oxidative stress suggesting an important role for it in Lewy body formation, another important hallmark of the disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 343
页数:17
相关论文
共 50 条
  • [41] The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease
    Jellinger, KA
    DRUGS & AGING, 1999, 14 (02) : 115 - 140
  • [42] Does neurosurgery still have a role in Parkinson's disease?
    不详
    AGE AND AGEING, 1999, 28 (04) : 339 - 339
  • [43] Does cannabis have a role in the treatment of Parkinson's disease?
    Carroll, CB
    Bain, P
    Teare, L
    Liu, XG
    Joint, C
    Wroath, C
    Parkin, S
    Fox, P
    Wright, D
    Hobart, J
    Zajicek, JP
    NEUROLOGY, 2004, 62 (07) : A330 - A330
  • [44] α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?
    Zheng, Huimin
    Shi, Changhe
    Luo, Haiyang
    Fan, Liyuan
    Yang, Zhihua
    Hu, Xinchao
    Zhang, Zhongxian
    Zhang, Shuo
    Hu, Zhengwei
    Fan, Yu
    Yang, Jing
    Mao, Chengyuan
    Xu, Yuming
    NEUROSCIENTIST, 2021, 27 (04): : 367 - 387
  • [45] Iron Deficiency in Parkinsonism: Region-Specific Iron Dysregulation in Parkinson's Disease and Multiple System Atrophy
    Visanji, Naomi P.
    Collingwood, Joanna F.
    Finnegan, Mary E.
    Tandon, Anurag
    House, Emily
    Hazrati, Lili-Naz
    JOURNAL OF PARKINSONS DISEASE, 2013, 3 (04) : 523 - 537
  • [46] Mapping of cellular iron using hyperspectral fluorescence imaging in a cellular model of Parkinson's disease
    Oh, Eung Seok
    Heo, Chaejeong
    Kim, Ji Seon
    Lee, Young Hee
    Kim, Jong-Min
    NANO-BIO SENSING, IMAGING, AND SPECTROSCOPY, 2013, 8879
  • [47] DOES VANADIUM PLAY A ROLE IN CELLULAR-REGULATION
    RAMASARMA, T
    CRANE, FL
    CURRENT TOPICS IN CELLULAR REGULATION, 1981, 20 : 247 - 301
  • [48] Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?
    Söderberg-Nauclér, C
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) : 219 - 246
  • [49] DOES NOREPINEPHRINE PLAY A CENTRAL CAUSATIVE ROLE IN THE PROCESS OF CARDIAC-HYPERTROPHY
    ROSSI, MA
    CARILLO, SV
    AMERICAN HEART JOURNAL, 1985, 109 (03) : 622 - 624
  • [50] Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease
    Vuuren, Marthinus Janse van
    Nell, Theodore Albertus
    Carr, Jonathan Ambrose
    Kell, Douglas B.
    Pretorius, Etheresia
    BIOMOLECULES, 2021, 11 (01) : 1 - 27